Skip to main content
See every side of every news story
Published loading...Updated

Permira seeks $4 billion for sale of contract drugmaker Cambrex, FT reports

Summary by Reuters
British private equity firm Permira has put its contract drugmaker Cambrex up for sale, targeting a valuation of as much as $4 billion, the Financial Times reported on Saturday, citing people familiar with the matter.

Bias Distribution

  • 100% of the sources are Center
100% Center

Factuality 

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

The Mighty 790 KFGO broke the news in on Saturday, September 6, 2025.
Sources are mostly out of (0)
News
For You
Search
BlindspotLocal